Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
出版年份 2021 全文链接
标题
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
作者
关键词
-
出版物
Diagnostics
Volume 11, Issue 11, Pages 2166
出版商
MDPI AG
发表日期
2021-11-23
DOI
10.3390/diagnostics11112166
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial.
- (2021) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.
- (2021) Matthew H. G. Katz et al. JOURNAL OF CLINICAL ONCOLOGY
- Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma
- (2021) Yoshifumi Noda et al. Abdominal Radiology
- European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
- (2021) G. Carioli et al. ANNALS OF ONCOLOGY
- Targeting KRAS: The Elephant in the Room of Epithelial Cancers
- (2021) Valeria Merz et al. Frontiers in Oncology
- Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
- (2021) Q. P. Janssen et al. BMC CANCER
- Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2
- (2021) Kim A. Reiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of deep learning image reconstruction in the prediction of resectability of pancreatic cancer: Diagnostic performance and reader confidence
- (2021) Peijie Lyu et al. EUROPEAN JOURNAL OF RADIOLOGY
- How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers
- (2021) Sun Kyung Jeon et al. EUROPEAN RADIOLOGY
- Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery?
- (2021) Kartik S. Jhaveri et al. CANCER IMAGING
- Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review
- (2021) T. H. Perik et al. Abdominal Radiology
- Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
- (2021) Roberto Alva-Ruiz et al. ANNALS OF SURGICAL ONCOLOGY
- Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
- (2020) Eileen M. O’Reilly et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
- (2020) Eva Versteijne et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
- (2020) Michael J Pishvaian et al. LANCET ONCOLOGY
- Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis
- (2020) Mao Ye et al. HPB
- Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9
- (2020) Haidy Nasief et al. Frontiers in Oncology
- Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
- (2020) Philip A Philip et al. Lancet Gastroenterology & Hepatology
- Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer
- (2020) Talia Golan et al. ANNALS OF SURGICAL ONCOLOGY
- ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.
- (2020) Paula Ghaneh et al. JOURNAL OF CLINICAL ONCOLOGY
- SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).
- (2020) Davendra Sohal et al. JOURNAL OF CLINICAL ONCOLOGY
- Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
- (2020) Takahiro Yokose et al. Cancer Medicine
- A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score
- (2020) Charlotte Maulat et al. Cancers
- Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma After FOLFIRINOX Chemotherapy and Chemoradiation Therapy
- (2020) Pierre-Emmanuel Colombo et al. ANNALS OF SURGICAL ONCOLOGY
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score
- (2020) Dong Wook Kim et al. RADIOLOGY
- Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-011968-11)
- (2020) Carolin Zimmermann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
- (2020) Khaled Y. Elbanna et al. Insights into Imaging
- Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
- (2020) R. Casolino et al. ANNALS OF ONCOLOGY
- Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
- (2020) Volker Kunzmann et al. Lancet Gastroenterology & Hepatology
- Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI
- (2019) D. M. Riviere et al. Abdominal Radiology
- A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
- (2019) R. Tuli et al. EBioMedicine
- Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study
- (2019) Alessandro Beleù et al. Cancers
- Appleby Procedure (Distal Pancreatectomy With Celiac Artery Resection) for Locally Advanced Pancreatic Carcinoma: Indications, Outcomes, and Imaging
- (2019) Roberto Cannella et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis
- (2019) Quisette P Janssen et al. JNCI-Journal of the National Cancer Institute
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
- (2019) Janet E. Murphy et al. JAMA Oncology
- Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
- (2019) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience
- (2019) Ahmed Hamdy et al. RADIOLOGY
- Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
- (2019) Laura Maggino et al. JAMA Surgery
- Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement
- (2019) Ijin Joo et al. RADIOLOGY
- Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
- (2019) Manisha Palta et al. Practical Radiation Oncology
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis
- (2019) Yoon Suk Lee et al. Scientific Reports
- White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals
- (2019) Naveen M. Kulkarni et al. Abdominal Radiology
- Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability
- (2019) Mariangela Dimarco et al. Abdominal Radiology
- White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease
- (2019) Naveen M. Kulkarni et al. Abdominal Radiology
- Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
- (2019) Amir A. Borhani et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Patient outcome according to the 2017 international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma
- (2019) J. Medrano et al. PANCREATOLOGY
- Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer
- (2018) Jin-Young Jang et al. ANNALS OF SURGERY
- CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis
- (2018) Bo Ram Kim et al. EUROPEAN RADIOLOGY
- International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
- (2018) Shuji Isaji et al. PANCREATOLOGY
- PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study
- (2018) Entesar Dalah et al. Translational Oncology
- Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT
- (2018) Satomi Kawamoto et al. Abdominal Radiology
- Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis
- (2018) Bhavik N. Patel et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study
- (2018) Anne-Marie Marion-Audibert et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy
- (2018) VALENTINA CIARAVINO et al. ANTICANCER RESEARCH
- Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
- (2018) Lilian Schwarz et al. BMC CANCER
- Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria
- (2018) Seung Baek Hong et al. RADIOLOGY
- CT perfusion and diffusion-weighted MR imaging of pancreatic adenocarcinoma: can we predict tumor grade using functional parameters?
- (2018) Jelena Djokić Kovač et al. ACTA RADIOLOGICA
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim analysis of perioperative modified FOLFIRINOX (mFOLFIRINOX) in resectable pancreatic cancer (PC).
- (2017) Michael Cecchini et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis
- (2017) Ali A. Mokdad et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial
- (2017) Knut Jørgen Labori et al. BMC Surgery
- Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis
- (2017) Manav Bhalla et al. Abdominal Radiology
- Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study
- (2017) Xiaojian Chen et al. PLoS One
- Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy
- (2016) Eric A. Mellon et al. ACTA ONCOLOGICA
- CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma
- (2016) Mathilde Wagner et al. EUROPEAN RADIOLOGY
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- (2016) Pascal Hammel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages
- (2016) Kezhong Tang et al. PANCREATOLOGY
- Dual-Energy Perfusion-CT in Recurrent Pancreatic Cancer – Preliminary Results
- (2016) F. Fritz et al. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
- Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
- (2016) Matthew H. G. Katz et al. JAMA Surgery
- Radiological evaluation of response to neoadjuvant treatment in pancreatic cancer
- (2016) C. Cassinotto et al. Diagnostic and Interventional Imaging
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Common and uncommon pitfalls in pancreatic imaging: it is not always cancer
- (2015) F. Vernuccio et al. Abdominal Radiology
- Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT
- (2014) Michelle M. McNamara et al. ABDOMINAL IMAGING
- Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy
- (2014) Christophe Cassinotto et al. RADIOLOGY
- Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
- (2014) Maximilian Bockhorn et al. SURGERY
- Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
- (2013) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Split-Bolus Spectral Multidetector CT of the Pancreas: Assessment of Radiation Dose and Tumor Conspicuity
- (2013) Olga R. Brook et al. RADIOLOGY
- Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
- (2013) Mahmoud M. Al-Hawary et al. RADIOLOGY
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
- (2012) Hiroshi Haeno et al. CELL
- Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: Optimization of energy level viewing significantly increases lesion contrast
- (2012) B.N. Patel et al. CLINICAL RADIOLOGY
- Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Pathologic Response to Preoperative Chemoradiation Therapy in Patients With Resectable T3 Pancreatic Cancer
- (2012) Hirotada Kittaka et al. WORLD JOURNAL OF SURGERY
- Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression
- (2012) Vikas Dudeja et al. HPB
- Small (≤20 mm) Pancreatic Adenocarcinomas: Analysis of Enhancement Patterns and Secondary Signs with Multiphasic Multidetector CT
- (2011) Soon Ho Yoon et al. RADIOLOGY
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations
- (2010) Jin Hee Kim et al. RADIOLOGY
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference
- (2009) Jean-Nicolas Vauthey et al. ANNALS OF SURGICAL ONCOLOGY
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
- Effects of Neoadjuvant Combined Chemotherapy and Radiation Therapy on the CT Evaluation of Resectability and Staging in Patients with Pancreatic Head Cancer
- (2009) Yeo-Eun Kim et al. RADIOLOGY
- Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy
- (2008) Mi-Suk Park et al. RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More